ABSTRACT
INTRODUCTION
Calcium oxalate stone disease is the most common metabolic abnormality associated with calcium urolithiasis. The cause of calcium oxalate stone is heterogeneous, involving both genetic and environmental factors. It is a multifactorial disorder resulting from the interaction between environmental influences and hormonal and genetic factors. Rendina et al in their study reported; genetic factors to be important determinants for kidney stone (1) . A recent report demonstrated MGP gene polymorphism to be associated with kidney stones formation (2) . Besides genetic and environmental factor, hormones also play a very significant role in stone formation (3) . In another study, the total urinary testosterone concentration was found lower among stone patients than among normal healthy subjects, suggesting that androgen may play a role in the pathogenesis of urolithiasis (4).
The VDR and AR genes are both members of nuclear receptor superfamily regulating the genes for hormone-response (5) . The transcriptional activity of the VDR gene is regulated in part by AR gene (6) . Both these nuclear receptors are liganddependent transcriptional regulatory proteins (7) . The VDR gene located on chromosome 12, is 5.6 kb in size. Several polymorphisms have been identified and their functional significance and potential effects on disease susceptibility have been investigated (8, 9) . Vitamin D produces its effect via the vitamin D receptor (VDR). Any genetic defect in VDR may change the calcium metabolism and increase the risk of stone formation. Allelic variations in the VDR gene may, at least partially, reflect the genetic component of urinary stone disease (10, 11, 12) . The AR, a member of the steroid receptor superfamily, is involved in various biological processes such as sexual differentiation, maturation and spermatogenesis (13) . The gene is located in the chromosome Xq11-q12 region and has a polymorphic cytosine, adenine and guanine (CAG) microsatellite on exon-1, which codes for variable-length glutamine repeats in the N-terminal domain of the AR protein (14) . A shorter allele has been shown to increase transactivation activity (15) . The CAG repeat length for the AR is related to different diseases like prostate diseases, including prostate carcinoma and BPH (16) and also urolithiasis (17) .
We thus chose these two steroid hormone receptors as candidate genes for kidney stone susceptibility. It may be possible that the AR may interact and influence VDR for the risk of stone formation. Genetic association studies are likely to shed light in our current understanding of their roles in the risk of urolithiasis. In the present study, we have evaluated the possible genetic association of two important steroid hormone receptors such as VDR and AR polymorphisms in the risk of urolithiasis in case-control study in Northern India.
MATERIALS AND METHODS
A total of 125 patients (mean age 40.0 ± 11.5 years), treated at the Urology clinic of our tertiary care hospital, Lucknow, India, between the period of November 2004 and January 2006 were enrolled in the study. The control group consisted of 150 unrelated healthy volunteers (mean age 41.5 ± 10.5 years), with no history of stone disease or of renal calcification. The diagnosis of urinary tract calculus was documented by a plain X-ray film, intravenous pyelography and renal ultrasound. Routine tests were done in form of urinary microscopic hematuria and renal ultrasonography in order to exclude any individual with renal calcification. Hypercalciuria was determined by 24-hr collected urine examination. Patients with urinary tract infection were excluded from the analysis. Healthy controls for the study were drawn from general population taking care of matching age, gender and ethnicity. The study was performed with the approval of the hospital ethical committee and informed consent was obtained from the subjects participating in the study.
DNA extraction: Five ml of blood was collected in EDTA vials from cases and controls. DNA was extracted from blood lymphocytes using 'salting out' method (18) . Table 1 shows the details of the VDR gene screening. The primers of the VDR gene (Fok-I, Taq-I and Apa-I) were used as reported earlier (19, 20, 21) .
Genotyping of VDR Gene by PCR-RFLP:

PCR Assay for AR Polymorphism by Gene Scan:
A fragment of Exon 1 of AR gene was Genotyped using the following primers (22) . F -5'CAG AAT CTG TTC CAG AGC GTG C 3' R -5'AAG GTT GCT GTT CCT CAT CCA G 3'
The forward primer was synthesized (ABI 392 oligosynthesizer, Perkin Elmer, Foster City, Calif) with 5'FAM (Carboxyfluorescein) label (Perkin Elmer) in order to analyze the PCR product in the automated DNA sequencer (ABI 377). Each reaction sample contained 10ng genomic DNA, 1X PCR buffer containing 1.5 mM MgCl 2 , 10pM of each primer, 200µM Deoxynucleotide triphosphates and 2U of AmpliTaq Gold (Perkin Elmer). Thermal cycling parameters consist of thirty PCR cycles of 1min at 94°C, 1 min at 60°C and 1 min at 72°C. The cycle programme was preceded by incubation at 94°C for 2min and was followed by a final extension at 72°C for 5min.
Gene Scan and Genotyping: For genescan 3.0 Pl of the PCR product was mixed with 0.2 Pl of ROX500 TM and 6.8 Pl of formamide. Upon, denaturation for 5 minute at 95°C and cooling for 5 minute on ice, the samples were run on 3730DNA analyzer (Applied Biosystems, USA). PCR and Genescan were repeated for all the samples to confirm the number of repeats. The raw data were further analyzed using GeneMapper software to obtain the allele (repeat) size. This work has been done at CCMB Hyderabad.
Statistical Analysis: Analysis of data was performed using the computer software SPSS (ver 11.5, Chicago Japan) for windows. Allele frequencies, genotype frequencies and carriage rates of patients and controls were compared using a 2x2 contingency table using Fisher's exact test. Mean, median, mode and standard deviation were calculated as descriptive in each group. Mean CAG repeats in patients and controls were compared by 't' test. The number of CAG repeats was examined as continuous. Differences were considered statistically significant for P<0.05. Odds ratios (OR) with 95% CI were calculated for disease susceptibility or severity in carriers of specific alleles. Haplotype frequencies and linkage disequilibrium were estimated using the expectationmaximization (EM) algorithm implemented in the SNPAnalyzer.
RESULTS
Frequency of VDR (Fok-I, Taq-I and Apa-I) gene polymorphism:
The distribution of genotypes of VDR gene (Fok-I, Taq-I and Apa-I) in control and renal stone patients are shown in Table 2 . Significant difference in the genotypic frequencies between patients and controls were observed for CAG repeat length distribution: Figure 1 shows the distribution of CAG repeats in patients and controls. The number of CAG repeats ranged from 12-38 in Stone patients and controls. The un-paired student's 't'-test demonstrated that mean number of CAG repeats in Stone patients (21.13 ± 3.54) was not significantly different from controls (21.84 ± 4.65) as evident from t-test (P=0.161). Median CAG repeat was 21 in both patients as well as controls. CAG repeats were categorized in two groups (more than and less than/equal to mean CAG repeat) and risk was calculated using binary logistic regression analysis but no significant association was established (P=0.489), Table 4 .
Association of stone formation according to gender:
We determined the VDR genotypic frequencies and CAG repeat distribution in male and female stone formers separately (Table  5 and 6). We observed significant difference in Ff of Fok-I and Aa of Apa-I gene polymorphism in males only showing 
DISCUSSION
Urolithiasis is a multifactorial pathology resulting from the interaction between environmental influences, hormonal and genetic factors (23) . It is still an enigmatic problem for biologist with very vague understanding of its pathogenesis and mode of early detection due to lack of well-established genetic marker. With the limited understanding of disease and susceptibility genes, functional polymorphism in genes involving, steriodogenesis, steroid action and metabolizing enzyme, could be major target of further studies in urolithiasis.
The VDR gene influence hormonal signal and regulates calcium homeostasis by affecting bone resorption and increasing calcium absorption. The allelic variations in the 3'-UTR region may affect the mRNA stability or change vitamin-D activity by affecting the regulation of translation and may cause a tendency for stone formation (12) . In the present study we observed a significant association of VDR Fok-I and Taq-I genotypes. The heterozygous genotype Ff of Fok-I and Tt of Taq-I carrying variant allele showed significantly higher risk for stone formation. The frequency of low producing genotype FF in Fok-I and TT Taq-I was higher in controls as compared to patients. Allele frequencies demonstrated that variant f allele showed significantly 1.7-folds higher risk for stone formation.
The ff and Ff forms of the VDR gene are associated with a decreased VDR efficiency (24) . The high prevalence of Ff genotype in our population is accord to (25) . In another study by (26) no association was observed with stone formation for VDR (Fok-I). In one of our previous study we reported a significant association of VDR (Fok-I) polymorphism with pediatric as well as adult nephrolithiasis. (27) . Besides Fok I, there are other known genetic polymorphisms in the VDR gene that cluster at the 3 l end like ApaI polymorphisms in the intron 8 and TaqI variant in intron 9. Association of Taq I and ApaI have also been reported with renal stone disease (28, 29) . In our population we observed that Tt genotype of Taq-I showed significant risk for stone formation, similar with (28), while no association was seen for ApaI genotypes. A recent report by Sezgin et al having no association between urolithiasis and VDR (ApaI, BsmI, and TaqI) gene variants (30) .
Vitamin D and Androgen Receptor Genes Polymorphisms in Urolithiasis
Association of AR gene with stone formation has been proved by animal studies showing that castrated male rats have a marked reduction in stone formation (31) leading to the hypothesis that androgen has a positive association with stone disease (32) . We examined the CAG repeat length in AR gene and observed that mean CAG repeats did not differ significantly in stone patients and controls (21 repeats in both groups). This observation is in accord to study by Chen et al (17) .
It is apparent that men have higher stone incidence rates than women, implying that there could be a relationship between urolithiasis among men and hormonal variations (33) . We therefore evaluated the association of VDR and AR genes according to gender also. We observed a significant difference in Ff of Fok-I and Aa of Apa-I genotypes in males showing higher risk while no association was seen in female group. Though short CAG repeat showed higher risk in males however the P-value did not reach significant. Chen et al observed a significant association of CAG repeat with stone formation and showed that long repeats are protective in men (17) .
Absorptive hypercalciuria is a common cause of kidney stones and cause may be an excessive intestinal absorption due to increase vitamin-D synthesis or alteration in the VDR gene. The involvement of VDR in calcium kidney stones has been speculate because half of the patients have idiopathic hypercalciurea, most of them with increase intestinal calcium absorption and low BMD (26). When we stratified our patients according to hypercacliuria and normocalciuria with all the three loci of VDR, it showed no significant difference, however, the mean CAG repeat was significantly higher in hypercalciuric patients showing higher urinary calcium excretion.
Short CAG repeats increases AR transactivation activity and thus increased efficiency to transmit growth signals (15) , which may maintain intestinal calcium absorption and urinary calcium excretion. We further evaluated the number of polyglutamine (CAG) repeats of the AR gene influence stone formation in conjunction with VDR since AR signaling and VDR action have been shown to be linked (7, 34) . Interestingly, the combined effect demonstrated 1.8-folds higher risk in patients with Tt genotype of Taq-I and short CAG repeat. Different polymorphisms of the VDR gene may interact with AR. It is possible that the transactivation efficiency associated with the various VDR genotypes is heterogeneous with respect to downstream genes, such that some genes are more efficiently transactivated by one genotype and other genes by another (6) . Currently there is not a single report showing the synergistic effect of these two steroidal hormones with urolithiasis. Epidemiological data support genetic susceptibility of urolithiasis (23, 12) but association of genetic polymorphisms with risk of urolithiasis is still incomprehensible. Both AR and VDR polymorphisms appear to preferentially confer risk for stone disease; however, larger and multicentric studies are suggestive to confirm these results.
The study, for the first time from the Indian subcontinent, represents our efforts to investigate the association of vitamin D receptor (Fok-I, Taq-I, Apa-I) and Androgen receptor gene variants in relation to urolithiasis. Thus, our results provided evidence to genetic association of FokI and TaqI VDR gene variants with renal stone formation. Fok-I and Apa-I showed higher risk for stone disease among male population. Long CAG repeat length was associated with hypercalciurea. Finally the combined effect of VDR and AR gene showed that patients with Tt genotype of Taq-I and short CAG repeat had higher risk for stone formation. Though this report confirms association of VDR polymorphisms with urolithiasis warrants further investigation in large cohort for susceptibility as well as functions allelic variants. In addition, measurement of the VDR and androgen levels in serum as well as their expression profiles in kidney tissue samples would have help in getting insights into their functional implications.
